Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measles-Mumps-Rubella Vaccine”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Large-scale testing (Phase 3)Study completedNCT00148941
What this trial is testing

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 4,209
Large-scale testing (Phase 3)Study completedNCT00985166
What this trial is testing

ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 801
Post-approval studies (Phase 4)Study completedNCT00388440
What this trial is testing

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Large-scale testing (Phase 3)Not Yet RecruitingNCT07406360
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Who this might be right for
Measles
GlaxoSmithKline 1,209
Testing effectiveness (Phase 2)Ended earlyNCT00258726
What this trial is testing

Immune Responses to Two Dose Varivax +/- MMR-II

Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableUnknownNCT05154097
What this trial is testing

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Who this might be right for
Measles Vaccine
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 190
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Post-approval studies (Phase 4)Looking for participantsNCT05758532
What this trial is testing

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Who this might be right for
Respiratory Tract InfectionsInfectionsAllergy+1 more
Laure Pittet, MD-PhD 500
Large-scale testing (Phase 3)Study completedNCT00871117
What this trial is testing

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 478
Testing effectiveness (Phase 2)Study completedNCT00986232
What this trial is testing

ProQuad Dose Selection Study (V221-011)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,551
Post-approval studies (Phase 4)Study completedNCT00731965
What this trial is testing

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile Rheumatoid
N.M. Wulffraat 140
Large-scale testing (Phase 3)Ended earlyNCT00839917
What this trial is testing

ProQuad™ in Healthy Children in Korea (V221-023)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT00192491
What this trial is testing

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Who this might be right for
Influenza
MedImmune LLC 1,200
Large-scale testing (Phase 3)Looking for participantsNCT06855160
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 900
Large-scale testing (Phase 3)Study completedNCT00109343
What this trial is testing

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,027
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Testing effectiveness (Phase 2)Study completedNCT00109278
What this trial is testing

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

Who this might be right for
Measles
Merck Sharp & Dohme LLC 1,100
Post-approval studies (Phase 4)Study completedNCT05161845
What this trial is testing

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Who this might be right for
ImmunotoxicityVaccine
Shanghai Institute Of Biological Products 1,068
Load More Results